RapportFondation 2025 V02 EN light - Flipbook - Page 53
2024 REPORT
AIMS OF THE PROGRAMME:
TO DETECT THE VIRUS EARLY.
TO TRANSFUSE ANTIBODY-RICH PLASMA.
TO DEVELOP A VACCINE.
RECENT ACHIEVEMENTS OF THE PROJECT:
IN LATE 2024, THE VACCINE DEVELOPED BY UTRECHT UNIVERSITY WAS TESTED FOR THE FIRST
TIME IN EUROPE IN REAL-WORLD CONDITIONS AT ROTTERDAM ZOO. SIX ELEPHANTS OVER FIVE
YEARS OLD WERE VACCINATED INITIALLY TO ASSESS THE SAFETY OF THE TREATMENT. PROVIDED
THERE ARE NO SIGNIFICANT SIDE EFFECTS, THE PROTOCOL WILL BE EXTENDED TO INCLUDE
YOUNG ELEPHANTS.
53
